KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 25th Apr 2024 ABUS stock ended at $2.72. This is 1.09% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.43% from a day low at $2.68 to a day high of $2.75.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Apr 30, 2021 $3.45 $3.57 $3.44 $3.47 949 812
Apr 29, 2021 $3.43 $3.57 $3.37 $3.51 1 159 892
Apr 28, 2021 $3.58 $3.58 $3.34 $3.42 1 287 327
Apr 27, 2021 $3.36 $3.52 $3.33 $3.46 1 464 324
Apr 26, 2021 $3.23 $3.37 $3.20 $3.28 1 178 848
Apr 23, 2021 $3.18 $3.29 $3.14 $3.25 753 947
Apr 22, 2021 $3.15 $3.28 $3.09 $3.19 1 364 709
Apr 21, 2021 $3.00 $3.16 $2.93 $3.14 798 792
Apr 20, 2021 $3.05 $3.07 $2.95 $2.99 1 209 090
Apr 19, 2021 $3.04 $3.18 $3.02 $3.03 1 299 285
Apr 16, 2021 $3.20 $3.20 $3.02 $3.07 1 989 236
Apr 15, 2021 $3.37 $3.38 $3.17 $3.20 1 012 618
Apr 14, 2021 $3.17 $3.39 $3.15 $3.32 1 203 569
Apr 13, 2021 $3.15 $3.19 $3.06 $3.17 1 041 531
Apr 12, 2021 $3.30 $3.34 $3.02 $3.11 1 471 611
Apr 09, 2021 $3.25 $3.38 $3.19 $3.30 930 608
Apr 08, 2021 $3.30 $3.36 $3.20 $3.29 1 032 973
Apr 07, 2021 $3.38 $3.38 $3.20 $3.24 771 257
Apr 06, 2021 $3.40 $3.47 $3.31 $3.36 1 190 082
Apr 05, 2021 $3.46 $3.51 $3.33 $3.39 833 175
Apr 01, 2021 $3.50 $3.55 $3.40 $3.43 1 418 883
Mar 31, 2021 $3.21 $3.40 $3.19 $3.33 1 186 056
Mar 30, 2021 $3.24 $3.31 $3.12 $3.15 976 884
Mar 29, 2021 $3.33 $3.35 $3.21 $3.26 816 741
Mar 26, 2021 $3.36 $3.44 $3.27 $3.36 857 512
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT